Cross-Sector entity
Ituri province is most often covered alongside World Health Organization, which appears in 6 of these 11 stories. Across a 26-day span, the pace is roughly 3 stories per week. The busiest single day carried 3. Coverage clusters in clinical-trial, which accounts for 3 of those 11, with the remainder spread across 5 other categories.
11 verified stories tracked
Last mentioned: 5d ago
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 73 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Ituri province is most often covered alongside World Health Organization, which appears in 6 of these 11 stories. Across a 26-day span, the pace is roughly 3 stories per week. The busiest single day carried 3. Coverage clusters in clinical-trial, which accounts for 3 of those 11, with the remainder spread across 5 other categories. The tracked stories average 2.5 original sources each. 73% of these stories carry negative sentiment. Ituri province appears in 11 tracked Cross-Sector stories published from July 25, 2026 through August 19, 2026.
Computed from the 11 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Ituri province. Shared-story counts are live from our verified record — not editorial picks.
High-level international visits
WHO Director-General Tedros Adhanom Ghebreyesus arrives in Kinshasa; Africa CDC head Jean Kaseya visits Bunia, warning that 80% of cases are from community spread.
Leadership Visits and Latest Data Released
Africa CDC Director-General Jean Kaseya visited Bunia, WHO Director-General Tedros arrived in Kinshasa; government update reported 3,802 cases and 1,707 deaths.
Healthcare workers' ultimatum
Healthcare workers in Mongbwalu issue a 24-hour ultimatum over unpaid wages, threatening escalation.
3,000 Cases Milestone
Total cases reach 3,075, with 1,354 deaths, amid healthcare strikes and calls for accelerated countermeasure development.
First Experimental Vaccine Volunteer Dosed
Oxford University reports that the first volunteer group has received its candidate vaccine specifically targeting Bundibugyo.
2,000 Cases Surpassed
Cumulative confirmed cases exceed 2,000, with rapid spread noted in conflict zones.
Staff strike at Rwampara General Hospital
Dozens of workers at the epicenter treatment center strike over two months of unpaid salaries, shutting the facility and blocking roads.
Virus spreads to two more provinces
Health Minister Kamba announces the outbreak has reached two additional provinces beyond Ituri, further complicating containment.
Experimental treatment study begins
A clinical study of two candidate Ebola treatments launches at a different treatment center in Ituri province, not the one that would later strike.
Uganda Declared Ebola‑Free
Neighboring Uganda discharged its last Ebola patient, ending its own transmission chain linked to the Congo outbreak.
Uganda declared Ebola-free
Uganda discharges its last Ebola patient and declares the country free of the disease.
Outbreak Declared
DR Congo announces its 17th Ebola outbreak, identifying the Bundibugyo strain as the cause.
Official outbreak declaration
Congolese authorities declare a Bundibugyo Ebola outbreak after weeks of undetected transmission due to initial misdiagnosis.
Eastern Congo's Bundibugyo Ebola outbreak has passed 2,300 deaths among at least 5,000 cases, and mobile artisanal gold miners are undermining containment. Health workers face unmonitored populations, unsafe sites, and no approved countermeasures for this Ebola species.
The current Ebola outbreak in eastern Congo is caused by Bundibugyo virus, a less common species with no approved treatment or vaccine. With 5,000+ cases and 2,300+ deaths, it reveals a critical gap in filovirus countermeasure development and rapid-response platforms.
Source: abcnews.com · krmg.com
With Ebola cases surpassing 4,000 and deaths at 1,850, African health authorities are shifting strategy toward community mobilization. The outbreak highlights critical gaps in public health infrastructure, from surveillance to testing, and the need for stronger local engagement.
Source: torontotelegraph.com · english.news.cn
The WHO director-general warns that Ebola cases in DRC are doubling weekly in hotspots, reaching 3,874 confirmed cases and 1,751 deaths. The US has committed over $500 million to the response, but health system and security gaps remain critical. Urgent investments in surveillance, health worker support, and community access are needed.
Source: freemalaysiatoday.com · bangkokpost.com
Congo’s Bundibugyo Ebola outbreak has surged to 3,802 cases and 1,707 deaths, highlighting an urgent need for vaccines and treatments. With no approved products available, two post‑exposure prophylaxis trials in Ituri and two vaccine trials in the UK and Canada are now underway, while nearly 80% of new cases elude contact tracing.
Source: wfmj.com · orlandosentinel.com
The Bundibugyo Ebola outbreak in DRC has killed 1,700 people as community transmission drives 80% of new cases, revealing critical gaps in digital contact tracing and surveillance. With no approved vaccines, health IT innovators face an urgent call to deploy mobile tracing, AI analytics, and rapid diagnostics. Ongoing clinical trials may offer hope, but the immediate need is for tech-enabled outbreak management.
Source: MedPage Today · greatlakesadvocate.com.au
A strike by Ebola frontline workers in Congo over two months of unpaid salaries reveals deep flaws in payroll management during health emergencies. Minister Kamba's admission of list tampering highlights the urgent need for HR technology and accountability in crisis compensation.
With 702 deaths and a spreading Bundibugyo outbreak, the strike at Congo's main Ebola treatment center threatens to accelerate transmission. The walkout exposes systemic weaknesses in outbreak workforce support that could undermine the entire containment effort.
Biotech's race to develop therapies for the Bundibugyo Ebola strain faces a new hurdle as a strike at Congo's outbreak epicenter disrupts critical clinical operations. The study of two candidate treatments, launched in early July, could be jeopardized by collapsed workforce morale at nearby facilities.
Source: mcall.com
DRC’s 17th Ebola outbreak has exploded to 3,075 cases and 1,354 deaths, with 1,000 new infections in just 10 days. The Bundibugyo strain has no approved vaccine or treatment, igniting a biotech race: Oxford University has dosed its first volunteer with an experimental vaccine, while other candidates are fast-tracked, creating high-stakes opportunities for pharma developers.
Source: english.aawsat.com · manilatimes.net
The fastest-growing Ebola outbreak in history is driven by the Bundibugyo virus, which lacks any approved vaccine or therapy. With over 2,100 cases and 864 deaths, biopharma companies face a pressing unmet need and a potential market for rapid filovirus countermeasure development.
Source: wral.com · breitbart.com
